 Cardiomyopathy, Dilated
"Cardiomyopathy, Dilated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Descriptor ID |
D002311
|
| MeSH Number(s) |
C14.280.195.160 C14.280.238.070
|
| Concept/Terms |
Cardiomyopathy, Dilated- Cardiomyopathy, Dilated
- Cardiomyopathies, Dilated
- Dilated Cardiomyopathies
- Dilated Cardiomyopathy
Cardiomyopathy, Familial Idiopathic- Cardiomyopathy, Familial Idiopathic
- Cardiomyopathies, Familial Idiopathic
- Familial Idiopathic Cardiomyopathies
- Familial Idiopathic Cardiomyopathy
- Idiopathic Cardiomyopathies, Familial
- Idiopathic Cardiomyopathy, Familial
- Cardiomyopathy, Congestive
- Cardiomyopathies, Congestive
- Congestive Cardiomyopathies
- Cardiomyopathy, Dilated, with Conduction Deffect1
- Cardiomyopathy, Dilated, CMD1A
- Dilated cardiomyopathy 1A
- 1As, Dilated cardiomyopathy
- Dilated cardiomyopathy 1As
- cardiomyopathy 1A, Dilated
- cardiomyopathy 1As, Dilated
- Cardiomyopathy, Dilated, Autosomal Recessive
- Cardiomyopathy, Dilated, 1a
- Cardiomyopathy, Dilated, With Conduction Defect 1
- Cardiomyopathy, Idiopathic Dilated
- Cardiomyopathies, Idiopathic Dilated
- Dilated Cardiomyopathies, Idiopathic
- Dilated Cardiomyopathy, Idiopathic
- Idiopathic Dilated Cardiomyopathies
- Idiopathic Dilated Cardiomyopathy
- Congestive Cardiomyopathy
- Cardiomyopathy, Dilated, LMNA
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Dilated".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Dilated".
This graph shows the total number of publications written about "Cardiomyopathy, Dilated" by people in this website by year, and whether "Cardiomyopathy, Dilated" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 4 | 1 | 5 | | 1991 | 5 | 2 | 7 | | 1992 | 4 | 3 | 7 | | 1993 | 2 | 2 | 4 | | 1994 | 6 | 0 | 6 | | 1995 | 6 | 0 | 6 | | 1996 | 4 | 0 | 4 | | 1997 | 5 | 0 | 5 | | 1998 | 2 | 0 | 2 | | 1999 | 7 | 4 | 11 | | 2000 | 2 | 1 | 3 | | 2001 | 4 | 0 | 4 | | 2002 | 5 | 0 | 5 | | 2003 | 3 | 0 | 3 | | 2004 | 4 | 1 | 5 | | 2005 | 4 | 3 | 7 | | 2006 | 1 | 2 | 3 | | 2007 | 4 | 1 | 5 | | 2008 | 4 | 1 | 5 | | 2009 | 5 | 0 | 5 | | 2010 | 2 | 0 | 2 | | 2011 | 4 | 2 | 6 | | 2012 | 8 | 2 | 10 | | 2013 | 5 | 0 | 5 | | 2014 | 4 | 1 | 5 | | 2015 | 7 | 3 | 10 | | 2016 | 7 | 0 | 7 | | 2017 | 7 | 2 | 9 | | 2018 | 8 | 2 | 10 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Dilated" by people in Profiles.
-
Chen SN, Lombardi R, Karmouch J, Tsai JY, Czernuszewicz G, Taylor MRG, Mestroni L, Coarfa C, Gurha P, Marian AJ. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations. Circ Res. 2019 03 15; 124(6):856-873.
-
Campbell NV, Weitzenkamp DA, Campbell IL, Schmidt RF, Hicks C, Morgan MJ, Irwin DC, Tentler JJ. "Omics" data integration and functional analyses link Enoyl-CoA hydratase, short chain 1 to drug refractory dilated cardiomyopathy. BMC Med Genomics. 2018 Dec 12; 11(1):110.
-
Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics. 2018 Nov 12; 19(1):812.
-
Myers VD, Gerhard GS, McNamara DM, Tomar D, Madesh M, Kaniper S, Ramsey FV, Fisher SG, Ingersoll RG, Kasch-Semenza L, Wang J, Hanley-Yanez K, Lemster B, Schwisow JA, Ambardekar AV, Degann SH, Bristow MR, Sheppard R, Alexis JD, Tilley DG, Kontos CD, McClung JM, Taylor AL, Yancy CW, Khalili K, Seidman JG, Seidman CE, McTiernan CF, Cheung JY, Feldman AM. Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals. JAMA Cardiol. 2018 10 01; 3(10):929-938.
-
Paldino A, De Angelis G, Merlo M, Gigli M, Dal Ferro M, Severini GM, Mestroni L, Sinagra G. Genetics of Dilated Cardiomyopathy: Clinical Implications. Curr Cardiol Rep. 2018 08 13; 20(10):83.
-
De Luca G, Campochiaro C, Dinarello CA, Dagna L, Cavalli G. Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition. Ann Intern Med. 2018 12 04; 169(11):819-820.
-
Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy. J Am Heart Assoc. 2018 07 12; 7(14).
-
Venardos N, Deng XS, Yao Q, Weyant MJ, Reece TB, Meng X, Fullerton DA. Simvastatin reduces the TLR4-induced inflammatory response in human aortic valve interstitial cells. J Surg Res. 2018 10; 230:101-109.
-
Ujfalusi Z, Vera CD, Mijailovich SM, Svicevic M, Yu EC, Kawana M, Ruppel KM, Spudich JA, Geeves MA, Leinwand LA. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity. J Biol Chem. 2018 06 08; 293(23):9017-9029.
-
Chen SN, Taylor MRG, Mestroni L. Modeling Cardiomyopathy and Arrhythmias in Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Circ Genom Precis Med. 2018 03; 11(3):e002088.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|